TERN vs XLU
Terns Pharmaceuticals Inc (TERN) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
XLU (XLU) common stock.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
XLU does not have a complete income-statement cache yet.
TERN currently screens at market cap $6.12B. XLU currently screens at market cap $0.
Not investment advice. Open the TERN and XLU stock pages for the full models.
Not investment advice.